Codiak BioSciences, Inc. Common Stock
CDAK
CDAK was delisted on the 4th of April, 2023.
51 hedge funds and large institutions have $145M invested in Codiak BioSciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
9% less funds holding
Funds holding: 56 → 51 (-5)
35% less capital invested
Capital invested by funds: $224M → $145M (-$78.2M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
98% less call options, than puts
Call options by funds: $3K | Put options by funds: $131K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.7M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$491K |
| 3 |
State Street
Boston,
Massachusetts
|
+$375K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$341K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$296K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$2.5M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$2.33M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$973K |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$566K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$361K |
CDAK Hedge Fund Activity: Q4 2021 in Review
51 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Codiak BioSciences, Inc. Common Stock (CDAK) for Q4 2021, worth a combined $145M — down 35% from $224M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CDAK and 5 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 15 added.
The largest buyer was BlackRock, adding an estimated $1.7M. The largest seller was Boxer Capital, cutting an estimated $2.5M.
- 51 institutional investors held Codiak BioSciences, Inc. Common Stock (CDAK) as of Q4 2021, down from 56 in Q3 2021.
- Funds reported $145M of Codiak BioSciences, Inc. Common Stock stock for Q4 2021, down 35% quarter-over-quarter.
- 5 funds opened new Codiak BioSciences, Inc. Common Stock positions in Q4 2021 and 9 closed out, a net change of -4 holders.
- The largest Codiak BioSciences, Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $1.7M added.
- The largest Codiak BioSciences, Inc. Common Stock seller in Q4 2021 was Boxer Capital, an estimated $2.5M sold.
Based on aggregated 13F filings for Q4 2021.